Search Results for "Blue Oval Pill With 68 Taro"

02:07 EDT 1st May 2017 | BioPortfolio

Matching Channels

Blue hues

Von Willebrand's Disease

von Willebrand disease (vWD) is the most common hereditary coagulation abnormality described in humans, although it can also be acquired as a result of other medical conditions. It arises from a qua...

Matching News

Better Sleep in the ICU: Blue Pill or Red Pill... or No Pill?

What is the best way to improve sleep in the ICU? Does pharmacologically induced sleep offer more benefit than sedation--or should we be focusing on promoting a non-drug approach? Anesthesiology

Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc

Taro Pharmaceutical Industries Ltd.Mariano Balaguer, (914) 345-9001VP, Chief Financial OfficerMariano.Balaguer@taro.comorWilliam J. Coote, (914) Read ...

Taro to Announce Third Quarter Results on February 9, 2017

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2016, after the c...

Taro Pharmaceutical Industries Ltd. (TARO) Raised to B at TheStreet

Taro Pharmaceutical Industries traded down 0.84% on Wednesday, hitting $117.29. 62,727 shares of the stock were exchanged.

5 BCBS affiliates now cover Myriad's breast cancer test

Independence Blue Cross, Blue Cross and Blue Shield of Kansas City, Horizon Blue Cross Blue Shield of New Jersey, Blue Cross  -More- 

BELLUS Health sells Thallion Pharmaceuticals subsidiary to Taro Pharmaceuticals

LAVAL, QC- BELLUS Health Inc. reports it has entered into a share purchase agreement with Taro Pharmaceuticals Inc. (Taro) for the sale of its wholly-owned subsidiary Thallion Pharmaceuticals Inc. as ...

Campaigners Call For The Morning After Pill To Be Made More Affordable – Grazia

GraziaCampaigners Call For The Morning After Pill To Be Made More AffordableGraziaFor anyone that's made that awkward lunch break trip to pick up the morning after pill only to be faced with a judgeme...

BRIEF-Strongbridge Biopharma announces acquisition of U.S. rights to Keveyis from Taro

* Strongbridge Biopharma Plc says taro is also eligible to receive additional future payments upon achievement of certain sales unit milestones

Matching PubMed Articles

Better Sleep in the Intensive Care Unit: Blue Pill or Red Pill… or No Pill?

Two-step identification of taro (Colocasia esculenta cv. Xinmaoyu) using specific psbE-petL and simple sequence repeat-sequence characterized amplified regions (SSR-SCAR) markers.

Colocasia esculenta cv. Xinmaoyu is an eddoe-type taro cultivar local to Taicang, Jiangsu Province, China; it is characterized by its pure flavor, glutinous texture, and high nutritional value. Due to...

Oxalate Content of Taro Leaves Grown in Central Vietnam.

Leaves were harvested from four different cultivars of Colocasia esculenta and three cultivars of Alocasia odora that were growing on nine different farms in central Vietnam. The total, soluble and in...

Involvement of prolyl isomerase PIN1 in the cell cycle progression and proliferation of hepatic oval cells.

Liver regenerates remarkably after toxic injury or surgical resection. In the case of failure of resident hepatocytes to restore loss, repopulation is carried out by induction, proliferation, and diff...

Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension.

Search Whole site using Google

Quick Search
Advertisement Advertisement